论文部分内容阅读
加《医学邮报》第17卷第26期(1981年)报道多伦多消息:加拿大医学研究委员会的研究员、外科教授福尔克(Rudy Falk)领导的多伦多大学研究组发现一种毒性最小、抗肿瘤效果显著的、新的免疫化学治疗方法。福尔克及其同事发现,经皮下注射小剂量抗肿瘤药5-氟尿嘧啶、氨甲喋吟后,能够产生对上述药物的抗体,并明显地促进全身的肿瘤治疗作用。福尔克对《医学邮报》说,据他看来,上述方法在化学治疗中仍然是新的,但在过去的20年却被忽视,或者对于药物产生的抗体被认为是无足轻重的现象。目前尚未进行临床试验,但最近在多伦多
Plus, Medical Post, Vol. 17, No. 26 (1981): The Canadian University of Toronto’s research team led by Rudy Falk, a professor and professor of surgery at the Canadian Medical Research Council, discovered a minimally toxic antitumor Significant new immunochemical treatment. Falk and his colleagues found that subcutaneous injections of low-dose antitumor drugs 5-fluorouracil and carbamazem can produce antibodies against these drugs and significantly promote systemic tumor treatment. Falk told the Medical Post that, according to him, the above method is still new in chemical treatment, but it has been ignored in the past 20 years, or antibodies produced by drugs are considered to be insignificant. No clinical trials have been conducted yet, but recently in Toronto